
- November/December digital edition 2026
- Volume 18
- Issue 06
When MEWDS doesn’t behave like MEWDS: A case study
In this case of multiple evanescent white dot syndrome, a 20-year-old Hispanic woman first presented with new onset floaters in the left eye.
Multiple evanescent white dot syndrome (MEWDS) most commonly presents in young to middle-aged (20 to 40 years old), myopic women as a unilateral white dot syndrome. Common symptoms include monocular blurred vision, photopsia, scotomas, and floaters.1 Symptoms may be preceded by a flu-like illness, and cases of MEWDS following vaccination have also been reported.1,2 The pathophysiology of MEWDS is not completely understood but is thought to involve immune-mediated inflammatory injury of the outer retina, particularly the photoreceptors.3,4
The case
A 20-year-old Hispanic woman presented with new onset floaters in the left eye. She described them as small gray translucent spots initially confined to the left side of her field, but had progressively enlarged, darkened, and extended into central vision. She denied photopsia, trauma, recent vaccination, and recent illness. Medical history was significant for endometriosis and irritable bowel syndrome.
She had a past ocular history of a single episode of HLA-A29–positive birdshot chorioretinopathy 6 years ago. She was treated with oral prednisone with resolution over 3 months.
During the exam, the patient’s best-corrected visual acuity was 20/20 right/left eye with mild myopia. Pupils, motility, confrontation fields, and color vision were normal. Amsler grid testing of the left eye revealed a large central circular scotoma, despite 20/20 vision, surrounded by multiple smaller circular scotomas (Figure 1). Dilated fundus exam of the left eye showed diffuse small white focal chorioretinal lesions surrounding the optic nerve (Figure 2a). The right eye showed normal findings (Figure 3a, b). Fundus autofluorescence of the left eye demonstrated scattered hyperautofluorescent lesions in a 360-degree peripapillary distribution (Figure 2b). Diagnosis of MEWDS was made and confirmed by a retinal ophthalmologist and observed till resolution was achieved.
One year later, the patient returned with nearly identical symptoms, but in the right eye. Humphrey 24-2 SITA Standard showed a dense inferotemporal defect contiguous with the blind spot, with scattered superior and nasal defects (Figure 4). Fundus photography and fundus autofluorescence (FAF) showed lesions surrounding the optic nerve of the right eye similar to those seen prior in the left eye a year ago (Figure 5a, b). The left eye during this visit showed normal findings, with no lesions (Figure 6a, b). The patient was diagnosed with MEWDS in the right eye and was referred to the retinal ophthalmologist for a second opinion. The diagnosis of MEWDS was later confirmed by the retinal specialist.
Testing makes the diagnosis
Ocular examination/fundus photos
Most commonly, a fundus exam will show numerous yellow-white lesions, usually less than 200 µm in size, concentrated within the perimacular and peripapillary area, and macular granulation. The lesions are localized within the deep retina, at the level of the outer retina and retinal pigment epithelium, so overlying retinal vessels cross them without interruption. These can be subtle during biomicroscopy, but fundus photo allows them to be more apparent.5 The patients often will also have foveal granulation, which is often present longer, even after the yellow-white lesions have resolved.6
Additional findings can include mild vitreous cell, foveal granulation, and optic disc inflammation.7
- FAF: During the acute phase, FAF demonstrates multiple scattered hyperautofluorescent spots. These abnormalities may be more numerous and extensive than the lesions visible clinically and may extend beyond the posterior pole.8
- Spectral domain optical coherence tomography (OCT): MEWDS primarily affects the outer retina, producing multifocal disruption of the ellipsoid and interdigitation zones with overlying focal outer-retinal hyperreflectivity that may extend toward or beyond the external limiting membrane. These findings reflect transient photoreceptor injury.7 Increased choroidal thickness has been reported in some cases during the acute phase, although this is not considered a defining finding.9
- Fluorescein angiography (FA): FA classically demonstrates early punctate hyperfluorescent lesions arranged in a “wreath-like” configuration.10
- Visual field testing: Visual field abnormalities vary in severity and type. An enlarged blind spot is a characteristic finding, although central, paracentral, or other field defects may also occur.11-13
Look-alikes to consider
Although upon presentation all conditions within the white dot syndromes should be considered, the following are ones to keep a close eye on when considering MEWDS. These differentials are similar in demographic, symptomology, and findings.14
- Acute zonal occult outer retinopathy (AZOOR): AZOOR produces a geographic lesion that is well demarcated by a hyperautofluorescent “AZOOR line” on FAF. OCT demonstrates an abrupt transition between relatively preserved retina and the affected zone, with disruption or loss of the outer retinal layers, particularly the ellipsoid zone (EZ). These structural changes correlate with a geographic visual field defect.15
- Multifocal choroiditis and punctate inner choroidopathy spectrum (MFC/PIC): Patients present with active inflammatory chorioretinal lesions that may persist or recur and evolve into punched-out chorioretinal scars. Inflammatory choroidal neovascularization may also develop.16,17 Vitritis is more commonly seen in MFC, whereas PIC typically has little or no intraocular inflammation.18
- Acute idiopathic blind spot enlargement: Patients typically present with photopsias and an enlarged blind spot despite minimal funduscopic findings. OCT and multifocal electroretinography can demonstrate peripapillary outer retinal dysfunction.19
- Acute macular neuroretinopathy: Patients develop reddish-brown parafoveal lesions that are best visualized on near-infrared reflectance imaging. OCT demonstrates hyperreflectivity involving the outer plexiform layer/outer nuclear layer, along with disruption of the EZ.20
- Birdshot chorioretinopathy: Commonly presents with chronic, bilateral posterior uveitis. Some signs include yellow-orange choroidal lesions, vitritis, multifocal choroiditis, and retinal vascular leakage with minimum anterior segment inflammation. Fluorescein angiography commonly demonstrates retinal vascular leakage. It is strongly associated with HLA-A29, typically affecting middle-aged adults.21,22
When to order labs
Laboratory testing is generally not necessary in a classic presentation of MEWDS. In atypical cases, targeted testing may be considered to exclude infectious or inflammatory mimickers, including syphilis, tuberculosis, sarcoidosis, Lyme disease, and Bartonella infection.
Treatment
MEWDS is typically a self-limited disease that resolves spontaneously without treatment. Most patients experience improvement in visual symptoms and resolution of the characteristic retinal findings over several weeks. Therefore, observation is generally appropriate for typical, uncomplicated MEWDS.23
Treatment may be considered in atypical cases with severe, progressive, prolonged, or vision-threatening disease. Systemic corticosteroids have been used in selected cases; however, evidence supporting treatment is limited, and there is no established standardized treatment regimen for MEWDS. Immunomodulators are commonly used as a second-line treatment of atypical cases.23
Case recurrences
Upon being diagnosed with the second episode of MEWDS in the right eye, the patient underwent blood work to ensure no active infectious or systemic inflammatory etiology; everything was returned as unremarkable. The patient experienced additional recurrent episodes in the right eye. The patient was started on oral prednisone and later switched to methotrexate therapy due to systematic adverse effects. She has since remained symptom-free and free of recurrent active lesions while maintained on oral methotrexate.
Take-home considerations
MEWDS is usually self-limited, but this case shows atypical cases may require more than just monitoring. Fundus photography and FAF are valuable tools in identifying lesions. Sequential bilateral involvement or repeated recurrences should prompt initiation of treatment. In these patients, timely treatment with corticosteroids or immunomodulators such as methotrexate can preserve vision and prevent further recurrences.
References
Ramakrishnan MS, Patel AP, Melles R, Vora RA. Multiple evanescent white dot syndrome: findings from a large Northern California cohort. Ophthalmol Retina. 2021;5(9):850-854. doi:10.1016/j.oret.2020.11.016
Zeng Y, Du Z, Shao C, Zhao M. Comprehensive insights into COVID-19 vaccine-associated multiple evanescent white dot syndrome (MEWDS): a systematic analysis of reported cases. Hum Vaccin Immunother. 2024;20(1):2350812. doi:10.1080/21645515.2024.2350812
Pichi F, Srvivastava SK, Chexal S, et al. En face optical coherence tomography and optical coherence tomography angiography of multiple evanescent white dot syndrome: new insights into pathogenesis. Retina. 2016;36(suppl 1):S178-S188. doi:10.1097/IAE.0000000000001255
Munk MR, Stillenmunkes R, Tillmann A, et al;
Multimodal Imaging in Uveitis (MUV) Taskforce . Evidence and consensus based imaging guidelines in multiple evanescent white dot syndrome multimodal imaging in Uveitis (MUV) Taskforce Report 6. Am J Ophthalmol. 2025;278:191-202. doi:10.1016/j.ajo.2025.06.039Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for multiple evanescent white dot syndrome. Am J Ophthal. 2021;228:198-204. doi:10.1016/j.ajo.2021.03.050
Mantovani A, Invernizzi A, Staurenghi G, Herbort CP Jr. Multiple evanescent white dot syndrome: a multimodal imaging study of foveal granularity. Ocul Immunol Inflamm. 2019;27(1):141-147. doi:10.1080/09273948.2017.1353104
Papasavvas I, Mantovani A, Tugal-Tutkun I, Herbort CP Jr. Multiple evanescent white dot syndrome (MEWDS): update on practical appraisal, diagnosis and clinicopathology; a review and an alternative comprehensive perspective. J Ophthalmic Inflamm Infect. 2021;11(1):45. doi:10.1186/s12348-021-00279-7
Furino C, Boscia F, Cardascia N, Alessio G, Sborgia C. Fundus autofluorescence and multiple evanescent white dot syndrome. Retina. 2009;29(1), 60-63. doi:10.1097/IAE.0b013e31818c5e04
Fiore T, Iaccheri B, Cerquaglia A, et al. Outer retinal and choroidal evaluation in multiple evanescent white dot syndrome (MEWDS): an enhanced depth imaging optical coherence tomography study. Ocul Immunol Inflamm. 2018;26(3):428-434. doi:10.1080/09273948.2016.1231329
Jampol LM, Sieving PA, Pugh D, Fishman GA, Gilbert H. Multiple evanescent white dot syndrome. I. clinical findings. Arch Ophthalmol. 1984;102(5):671-674. doi:10.1001/archopht.1984.01040030527008
Borruat FX, Othenin-Girard P, Safran AB. Multiple evanescent white dot syndrome. Article in French. Klin Monbl Augenheilkd. 1991;198(5):453-456. doi:10.1055/s-2008-1046009
Hamed LM, Glaser JS, Gass JD, Schatz NJ. Protracted enlargement of the blind spot in multiple evanescent white dot syndrome. Arch Ophthalmol. 1989;107(2):194-198. doi:10.1001/archopht.1989.01070010200022
Kimmel AS, Folk JC, Thompson HS, Strnad LS. The multiple evanescent white-dot syndrome with acute blind spot enlargement. Am J Ophthalmol. 1989;107(4):425-426. doi:10.1016/0002-9394(89)90669-7
Gass JD, Agarwal A, Scott IU. Acute zonal occult outer retinopathy: a long‑term follow‑up study. Am J Ophthalmol. 2002;134(3):329‑339. doi:10.1016/s0002-9394(02)01640-9
Mrejen S, Khan S, Gallego-Pinazo R, Jampol LM, Yannuzzi LA. Acute zonal occult outer retinopathy: a classification based on multimodal imaging. JAMA Ophthalmol. 2014;132(9):1089-1098. doi:10.1001/jamaophthalmol.2014.1683
Dreyer RF, Gass DJ. Multifocal choroiditis and panuveitis. a syndrome that mimics ocular histoplasmosis. Arch Ophthalmol. 1984;102(12):1776-1784. doi:10.1001/archopht.1984.01040031440019
Jung JJ, Khan S, Mrejen S, et al. Idiopathic multifocal choroiditis with outer retinal or chorioretinal atrophy. Retina. 2014;34(7):1439-1450. doi:10.1097/IAE.0000000000000079
Gilbert RM, Niederer RL, Kramer M, et al. Differentiating multifocal choroiditis and punctate inner choroidopathy: a cluster analysis approach. Am J Ophthalmol. 2020;213:244-251. doi:10.1016/j.ajo.2020.01.031
Spaide RF, Koizumi H, Freund KB. Photoreceptor outer segment abnormalities as a cause of blind spot enlargement in acute zonal occult outer retinopathy-complex diseases. Am J Ophthalmol. 2008;146(1):111-120. doi:10.1016/j.ajo.2008.02.027
Bhavsar KV, Lin S, Rahimy E, et al. Acute macular neuroretinopathy: a comprehensive review of the literature. Surv Ophthalmol. 2016;61(5):538-565. doi:10.1016/j.survophthal.2016.03.003
Minos E, Barry RJ, Southworth S, et al. Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment. Orphanet J Rare Dis. 2016;11(1):61. doi:10.1186/s13023-016-0429-8
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for birdshot chorioretinitis. Am J Ophthalmol. 2021;228:65-71. doi:10.1016/j.ajo.2021.03.059
Fouad YA, Bianco L, Ramtohul P, et al. Multiple evanescent white dot syndrome: typical, atypical, and secondary variants. Prog Retin Eye Res. 2026;110:101420. doi:10.1016/j.preteyeres.2025.101420
Articles in this issue
about 1 month ago
The screen time question: What to ask and when to look deeperabout 2 months ago
Back-to-school eye exams: A critical window for myopia management3 months ago
Contact lenses of the futureRelated to this article








